Centagenetix is a start-up having building foundations on the investigations of the founders to develop a therapeutic or diagnostic products for treatment of human aging process. Apart from the complexity of the deal, related groundwork incite me to make a judgement as to invest in the company. The idea behind Centagenetix of finding a longevity gene and researching the treatment and diagnosis has a potential future and the investment can give us prolific returns.
The prospective objective of Centagnetix is to research the field of genetics of aging and age-related diseases. Centagenetix is based on the facts that the gene found on the chromosome 4 can be the answer to longevity and also be the base for therapeutic or diagnosing factor for age related diseases. The decision to start the company was laid on the initial points of identifying the specific gene involved, determination of their function and development of drugs. This time-consuming and expensive process requiring investments and strong research work. If the research continues and a final outcome is well evidence based then this can lead to a multi-million profit and the strong impact on health level can be laid.
Just by considering the funding of the project by Ellison foundations in its initiation process of research the higher investment and better aftermath can be foreseen. Decision to sub-contract with Qiagen turned out to be helpful as far as SNP analysis is considered. Also it lead to recruiting the potential employee of Qiagen Karen Headine as CEO of Centagenetix. Strong academic researchers are the founders and thus it will help to keep up with the research.The initial deal with MPM on investment stretches that on $5 million of investment, it owns 45% of the c...
... middle of paper ...
...erapeutic test for age related diseases till prevention of aging can be commercialized and the opportunity cost for these things are way higher. Centagenetix has a promising future as far as sales are considered once they get their facts and researches to be precise and on line. The foundation of the project is the unique and novel idea of finding the longevity gene which leads to provide an array of opportunity in fields of anti-aging therapeutics or diagnosis. The connection between these genes with the age related disease gene expressions can also be promoted and used to find diagnosing and therapeutic measures for diseases like Alzheimer’s, diabetes type 2 and many more.
Thus as far as investing in Centagenetix is considered, I infer it would be risky but after looking at the prospects the company has to offer it indeed has a better outcome in the upcoming time.
...ck trends past performance is an indicator of future performance. Therefore, investors should proceed with caution when investing in Champion Enterprise.
The CNS Company is already a successful company due to the achievements of its breathing right strips. In my analysis we learned that they already do a lot of things right. What they need to be aware of is the different economical situations in the global marketplace, there are different ways that the product is approved abroad, and there is competition lurking. CNS needs to continue to leverage their strengths, but capitalize on their opportunities and benchmark the competition.
I recommend a strong buy on Cisco’s stock with a target price of $32.50, a 50% upside from its current price. Cisco has a solid competitive advantage, because there are not many strong competitors in the market. The other firms show a higher P/E ratio than Cisco because they have a lower market share. The company shows a constant growth. Cisco markets its products globally with the highest market shares than its competitors. The main risks for Cisco are worsening of economic conditions or exchange rates. The company has a good growth in sales, which will lead higher profits. The company also gives out an annualized dividend to its shareholders every year.
Meeting the changing needs of healthcare today is a challenge for any organization. Meeting the challenging needs of tomorrow is even more perplexing. Centura Health, however, has a strategic plan in place for addressing the health care needs of the citizens in Colorado and Kansas for the next decade. Centura Health 2020 is designed to transform the future of health care for their patients and their surrounding communities. Using three pillars to define their vision, Centura Health plans to strengthen their foundation, move upstream to manage health, and create systems of care. With a focus on wellness and affordable care, their slogan for their strategic plan, “get better, get different” sums up their intentions. With their solid, well thought-out
“Are Telomeres the Key to Aging and Cancer?” Learn.Genetics.11 February 2014. University of Utah. http://learn.genetics.utah.edu/content/chromosomes/Telomeres/
Humans undergo several stages during their lifetime including growth, development, reproduction and senescence. Senescence is defined as the deteriorative biological changes that organisms experience as they age eventually leading to death. These changes include low metabolism, a weak immune system, memory loss, poor vision and loss of hearing. Senescence begins in humans during their post-reproductive years. However, gerontology research has shown that individuals who reproduce late have longer life spans compared to individuals who reproduce early. Nonetheless, it does not indicate that senescence is inevitable. All organisms experience senescence, but at different rates and time. Many genetic diseases such as Alzheimer’s disease and Huntington’s disease are prevalent in older individuals and the symptoms being to appear in middle adulthood. The causes of genetic diseases and disabilities in older individuals are explained by three evolutionary theories: antagonistic pleiotropy theory, mutation accumulation theory and disposable soma theory. These theories suggest that favorable natural selection and heavy allocation of resources for somatic maintenance during the reproductive period decreases the chances of genetic diseases in younger individuals.
Medical science has undergone a great revolution, it is getting better and more advanced than it was some decades back. In spite of such breakthrough advancement there are several diseases that don’t have a cure yet. A very hefty amount is being spent every day
Alzheimer’s disease is a complex illness that affects the brain tissue directly and undergoes gradual memory and behavioral changes which makes it difficult to diagnose. It is known to be the most common form of dementia and is irreversible. Over four million older Americans have Alzheimer’s, and that number is expected to triple in the next twenty years as more people live into their eighties and nineties. (Johnson, 1989). There is still no cure for Alzheimer’s but throughout the past few years a lot of progress has been made.
Oeseburg, H., de Boer, R.,A., van Gilst, W.,H., & van, d. H. (2010). Telomere biology in healthy aging and disease. Pflügers Archiv - European Journal of Physiology, 459(2), 259-68. doi:http://dx.doi.org/10.1007/s00424-009-0728-1
The World Health Organization (WHO) indicates that health conditions associated with the ageing process are arthritis, stroke, heart disease, cancer and diabetes. These health concerns can be avoided...
Over the past decade, scientists have made significant advancements in the treatment of certain diseases. Unfortunately, just like any new product, the cost of developing these new technologies and treatments is extremely high. Plus, unlike other technology, heath technolo...
SÍTAR, M.E., YANAR, K., AYDIN, S. and ÇAKATAY, U., CURRENT ASPECTS OF AGEING THEORIES AND CLASSIFICATION ACCORDING TO MECHANISMS. .
Investment opportunities all over the world are unending. There are millions of products and services that are potential game changers for the Embry Investment Group. My job as your consultant is to analyze the market and recommend the best possible investment for today and the future of the Embry Investme...
If Lars decides to invest around $6 million more in research and development, it is highly risky as the company’s survival depends largely on the success of the launch of Ray’s new product into the market.
The company believes in working together and collaborating with other industries on new technology to minimize the environmental footprint. The company wants to sustain a relationship with it partners and employees. Also the CNR has a human rights code of conduct which every employee has to accept before they become a member of the CNR family. Over the past 5 years the company has shown a significant increase in their stocks and they had a 74% increase from 2010-2014. They company had one of the most tremendous drops in 2013 due to their oil spill. The sales did very well too, in 2010 they had $14,000 million and in 2014 they ended with $21,000 million. CNR has established a great profile which has been a big contribution to their financial success of the